Clinical trial
Research Genetic Testing for Primary Ciliary Dyskinesia Using a Panel of Genes
NCT02389049 is registered in ClinicalTrials.gov with University of North Carolina, Chapel Hill as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Research Genetic Testing for Primary Ciliary Dyskinesia Using a Panel of Genes
- Lead sponsor
- University of North Carolina, Chapel Hill
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 28, 2015
- Completion date
- July 31, 2018
- Enrollment
- 320 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
kartagener syndrome, primary ciliary dyskinesia